

WE CONNECT THE BEST TREATMENTS WITH THE BRIGHTEST MINDS

MEDSIR is a company founded by scientific experts in 2012. We are dedicated to the design and management of strategic clinical trials in oncology, from study conception to the publication of study results.
MEDSIR favors a new model for collaborative clinical research in oncology development that aims to combine the highest scientific value with the strategic development of novel cancer treatments, with the final goal of benefiting cancer patients worldwide. Our goal is to generate win-win scenarios for all stakeholders involved in independent clinical research.
TOGETHER WE CAN BUILD A BRIGHTER FUTURE
13 YEARS OF INNOVATIVE CLINICAL RESEARCH

From Barcelona to Boston, and with a presence in over 14 countries, today we’re celebrating more than just an anniversary. We’re celebrating 13 years dedicated to a mission that drives us every day: advancing cancer research globally through innovation, scientific excellence and international collaboration.

MEDSIR IN NUMBERS

>40
INDUSTRY FUNDERS
>196
SITES
>65
TRIALS DEVELOPED
>615
RESEARCH
COLLABORATORS
>1000
IDEAS
GENERATED
>120
STAFF
DEDICATED
>2633
PATIENTS
RECRUITED
OUR STUDIES

Some examples of MEDSIR ideas matured into strategic clinical trials.